Recent Research | Page 16 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes Feb 2013 Br J Haematol myelodysplastic syndromes (MDS)
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes Sep 2016 2016 Sep 21 myelodysplastic syndromes (MDS)
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry Nov 2013 Leuk Res myelodysplastic syndromes (MDS)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Feb 2017 Leukemia myelodysplastic syndromes (MDS)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs. de novo myelodysplastic syndromes: A report on behalf of the MDS clinical research consortium Jan 2017 Leukemia myelodysplastic syndromes (MDS)
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the Europ Jun 2016 Biol Blood Marrow Transplant myelodysplastic syndromes (MDS)
Comparison of Rabbit Antithymocyte Globulin (R-ATG) and Jurkat Cell-Reactive Anti-T Lymphocyte Globulin (ATG-F) as a First-line Treatment for Children with Aplastic Anemia Feb 2014 Exp Hematol aplastic anemia
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides Oct 2015 Leukemia
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children Jan 2013 Blood aplastic anemia
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes Apr 2014 Br J Haematol myelodysplastic syndromes (MDS)